IWYND Trademark

Trademark Overview

On Tuesday, November 12, 2019, a trademark application was filed for IWYND with the United States Patent and Trademark Office. The USPTO has given the IWYND trademark a serial number of 88689185. The federal status of this trademark filing is REGISTERED as of Tuesday, February 1, 2022. This trademark is owned by AstraZeneca AB. The IWYND trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
iwynd

General Information

Serial Number88689185
Word MarkIWYND
Filing DateTuesday, November 12, 2019
Status700 - REGISTERED
Status DateTuesday, February 1, 2022
Registration Number6631063
Registration DateTuesday, February 1, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, February 1, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 28, 20211(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, November 22, 2021NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 22, 2021TEAS DELETE 1(B) BASIS RECEIVED
Monday, December 27, 2021EXTENSION 2 GRANTED
Tuesday, December 14, 2021EXTENSION 2 FILED
Monday, December 27, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 14, 2021TEAS EXTENSION RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 20, 2021EXTENSION 1 GRANTED
Thursday, May 20, 2021EXTENSION 1 FILED
Thursday, May 20, 2021TEAS EXTENSION RECEIVED
Tuesday, December 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 20, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 3, 2020ASSIGNED TO LIE
Friday, August 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 24, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 24, 2020NON-FINAL ACTION E-MAILED
Monday, February 24, 2020NON-FINAL ACTION WRITTEN
Saturday, February 15, 2020ASSIGNED TO EXAMINER
Tuesday, November 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 15, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

iwynd disorders diseases pharmaceutical anemia substances preparations nervous system inflammation infection